The interaction of the polypeptide chain elongation factor Tu (EF‐Tu) with the antibiotic kirromycin and tRNA has been studied by measuring the extent of protein modification with N‐tosyl‐L‐phenylalanine chloromethylketone (TPCK) and N‐ethylmaleimide (NEM). Kirromycin protects both EF‐Tu.GDP and EF‐Tu.GTP against modification with TPCK. Binding of aminoacyl‐tRNA added at increasing concentrations to a solution of 40 microM EF‐Tu.GDP.kirromycin complex re‐exposes the TPCK target site on the protein. However, when the aminoacyl‐tRNA concentration is raised beyond 20 microM, TPCK labeling drops again and is blocked completely at approximately 300 microM aminoacyl‐tRNA. By contrast, addition of uncharged tRNA or N‐ acetylaminoacyl ‐tRNA enhances TPCK labeling of the protein over the entire tRNA concentration range studied. These data strongly suggest that kirromycin induces in EF‐Tu.GDP an additional tRNA binding site that can bind uncharged tRNA, aminoacyl‐tRNA, and N‐ acetylaminoacyl ‐tRNA. Support for this assumption is provided by measuring the modification of EF‐Tu.GDP with the sulfhydryl reagent NEM. Moreover, NEM modification also indicates an additional tRNA binding site on EF‐Tu.GTP.kirromycin, which could not be detected with TPCK. Mapping of the tryptic peptides of EF‐Tu.GDP labeled with [14C]TPCK revealed only one target site for this agent, i.e., cysteine‐81. Modification occurred at the same site in the presence and in the absence of kirromycin and uncharged tRNA.(ABSTRACT TRUNCATED AT 250 WORDS)